1001 - Document - Cover Page
link:presentationLink
link:definitionLink
link:calculationLink
1002 - Statement - Consolidated Balance Sheets
link:presentationLink
link:definitionLink
link:calculationLink
1003 - Statement - Consolidated Balance Sheets (Parenthetical)
link:presentationLink
link:definitionLink
link:calculationLink
1004 - Statement - Consolidated Statements of Income (Loss)
link:presentationLink
link:definitionLink
link:calculationLink
1005 - Statement - Consolidated Statements of Income (Loss) (Parenthetical)
link:presentationLink
link:definitionLink
link:calculationLink
1006 - Statement - Consolidated Statements of Comprehensive Income (Loss)
link:presentationLink
link:definitionLink
link:calculationLink
1007 - Statement - Consolidated Statements of Comprehensive Income (Loss) (Parenthetical)
link:presentationLink
link:definitionLink
link:calculationLink
1008 - Statement - Consolidated Statements of Changes in Equity
link:presentationLink
link:definitionLink
link:calculationLink
1009 - Statement - Consolidated Statements of Changes in Equity (Parenthetical)
link:presentationLink
link:definitionLink
link:calculationLink
1010 - Statement - Consolidated Statements of Cash Flows
link:presentationLink
link:definitionLink
link:calculationLink
999001 - Disclosure - Basis of presentation
link:presentationLink
link:definitionLink
link:calculationLink
999002 - Disclosure - Certain transactions
link:presentationLink
link:definitionLink
link:calculationLink
999003 - Disclosure - Revenue from contracts with customers
link:presentationLink
link:definitionLink
link:calculationLink
999004 - Disclosure - Inventories
link:presentationLink
link:definitionLink
link:calculationLink
999005 - Disclosure - Identifiable Intangible Assets
link:presentationLink
link:definitionLink
link:calculationLink
999006 - Disclosure - Goodwill
link:presentationLink
link:definitionLink
link:calculationLink
999007 - Disclosure - Debt obligations
link:presentationLink
link:definitionLink
link:calculationLink
999008 - Disclosure - Derivative instruments and hedging activities
link:presentationLink
link:definitionLink
link:calculationLink
999009 - Disclosure - Legal Settlements and Loss Contingencies
link:presentationLink
link:definitionLink
link:calculationLink
999010 - Disclosure - Commitments and contingencies
link:presentationLink
link:definitionLink
link:calculationLink
999011 - Disclosure - Income taxes
link:presentationLink
link:definitionLink
link:calculationLink
999012 - Disclosure - Other assets impairments, restructuring and other items
link:presentationLink
link:definitionLink
link:calculationLink
999013 - Disclosure - Earnings (Loss) per share
link:presentationLink
link:definitionLink
link:calculationLink
999014 - Disclosure - Accumulated other comprehensive income (loss)
link:presentationLink
link:definitionLink
link:calculationLink
999015 - Disclosure - Segments
link:presentationLink
link:definitionLink
link:calculationLink
999016 - Disclosure - Fair value measurement
link:presentationLink
link:definitionLink
link:calculationLink
999017 - Disclosure - Certain transactions (Tables)
link:presentationLink
link:definitionLink
link:calculationLink
999018 - Disclosure - Revenue from contracts with customers (Tables)
link:presentationLink
link:definitionLink
link:calculationLink
999019 - Disclosure - Inventories (Tables)
link:presentationLink
link:definitionLink
link:calculationLink
999020 - Disclosure - Identifiable Intangible Assets (Tables)
link:presentationLink
link:definitionLink
link:calculationLink
999021 - Disclosure - Goodwill (Tables)
link:presentationLink
link:definitionLink
link:calculationLink
999022 - Disclosure - Debt obligations (Tables)
link:presentationLink
link:definitionLink
link:calculationLink
999023 - Disclosure - Derivative instruments and hedging activities (Tables)
link:presentationLink
link:definitionLink
link:calculationLink
999024 - Disclosure - Other assets impairments, restructuring and other items (Tables)
link:presentationLink
link:definitionLink
link:calculationLink
999025 - Disclosure - Earnings (Loss) per share (Tables)
link:presentationLink
link:definitionLink
link:calculationLink
999026 - Disclosure - Accumulated other comprehensive income (loss) (Tables)
link:presentationLink
link:definitionLink
link:calculationLink
999027 - Disclosure - Segments (Tables)
link:presentationLink
link:definitionLink
link:calculationLink
999028 - Disclosure - Fair Value Measurement (Tables)
link:presentationLink
link:definitionLink
link:calculationLink
999029 - Disclosure - Certain Transactions - Other Transactions - Additional Information (Detail)
link:presentationLink
link:definitionLink
link:calculationLink
999030 - Disclosure - Certain transactions - Summary of Assets Acquired, liabilities Assumed (Detail)
link:presentationLink
link:definitionLink
link:calculationLink
999031 - Disclosure - Certain Transactions - Business Acquisitions - Summary of Major Classes of Assets and Liabilities Included as Held for Sale (Detail)
link:presentationLink
link:definitionLink
link:calculationLink
999032 - Disclosure - Revenue from Contracts with Customers - Additional Information (Detail)
link:presentationLink
link:definitionLink
link:calculationLink
999034 - Disclosure - Revenue from Contracts with Customers - Schedule of Sales Reserves and Allowances (Detail)
link:presentationLink
link:definitionLink
link:calculationLink
999035 - Disclosure - Inventories - Summary of Inventories (Detail)
link:presentationLink
link:definitionLink
link:calculationLink
999036 - Disclosure - Identifiable Intangible Assets - Additional Information (Detail)
link:presentationLink
link:definitionLink
link:calculationLink
999037 - Disclosure - Identifiable Intangible Assets - Summary of Identifiable Intangible Assets (Detail)
link:presentationLink
link:definitionLink
link:calculationLink
999038 - Disclosure - Goodwill - Summary of Changes in the Carrying Amount of Goodwill by Segment (Detail)
link:presentationLink
link:definitionLink
link:calculationLink
999039 - Disclosure - Goodwill - Summary of Changes in the Carrying Amount of Goodwill by Segment (Parenthetical) (Detail)
link:presentationLink
link:definitionLink
link:calculationLink
999040 - Disclosure - Debt Obligations - Schedule of Short-term Debt (Detail)
link:presentationLink
link:definitionLink
link:calculationLink
999041 - Disclosure - Debt Obligations - Schedule of Short-term Debt (Parenthetical) (Detail)
link:presentationLink
link:definitionLink
link:calculationLink
999042 - Disclosure - Debt Obligations - Schedule of Senior Notes and Loans (Detail)
link:presentationLink
link:definitionLink
link:calculationLink
999043 - Disclosure - Debt Obligations - Schedule of Senior Notes and Loans (Parenthetical) (Detail)
link:presentationLink
link:definitionLink
link:calculationLink
999044 - Disclosure - Debt Obligations - Additional Information (Detail)
link:presentationLink
link:definitionLink
link:calculationLink
999045 - Disclosure - Derivative Instruments and Hedging Activities - Summary of Classification and Fair Values of Derivative Instruments (Detail)
link:presentationLink
link:definitionLink
link:calculationLink
999046 - Disclosure - Derivative Instruments and Hedging Activities - Summary of Pre-tax (Gains) Losses From Derivatives Designated in Cash Flow Hedging Relationships (Detail)
link:presentationLink
link:definitionLink
link:calculationLink
999047 - Disclosure - Derivative Instruments and Hedging Activities - Summary of Pre-tax (Gains) Losses From Derivatives Not Designated in as Hedging Instruments (Detail)
link:presentationLink
link:definitionLink
link:calculationLink
999048 - Disclosure - Derivative Instruments and Hedging Activities - Additional Information (Detail)
link:presentationLink
link:definitionLink
link:calculationLink
999049 - Disclosure - Legal Settlements and Loss Contingencies - Additional Information (Detail)
link:presentationLink
link:definitionLink
link:calculationLink
999050 - Disclosure - Commitments and Contingencies - Contingencies - Additional Information (Detail)
link:presentationLink
link:definitionLink
link:calculationLink
999051 - Disclosure - Income Taxes - Additional Information (Detail)
link:presentationLink
link:definitionLink
link:calculationLink
999052 - Disclosure - Other assets impairments, restructuring and other items - Schedule of Other Assets Impairments, Restructuring and Other Items (Detail)
link:presentationLink
link:definitionLink
link:calculationLink
999053 - Disclosure - Other assets impairments, restructuring and other items - Components of costs associated with restructuring plan including costs related to exit and disposal activities (Detail)
link:presentationLink
link:definitionLink
link:calculationLink
999054 - Disclosure - Other assets impairments, restructuring and other items - Summary of Restructuring Accruals (Detail)
link:presentationLink
link:definitionLink
link:calculationLink
999055 - Disclosure - Other assets impairments, restructuring and other items - Additional Information (Detail)
link:presentationLink
link:definitionLink
link:calculationLink
999056 - Disclosure - Earnings (Loss) per share - Schedule of Earnings per Share (Detail)
link:presentationLink
link:definitionLink
link:calculationLink
999057 - Disclosure - Earnings (Loss) per share - Additional Information (Detail)
link:presentationLink
link:definitionLink
link:calculationLink
999058 - Disclosure - Accumulated other comprehensive income (loss) (Detail)
link:presentationLink
link:definitionLink
link:calculationLink
999059 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Parenthetical) (Detail)
link:presentationLink
link:definitionLink
link:calculationLink
999060 - Disclosure - Segments - Summary of Segment Profit (Detail)
link:presentationLink
link:definitionLink
link:calculationLink
999061 - Disclosure - Segments - Schedule of Revenues by Major Products and Activities (Detail)
link:presentationLink
link:definitionLink
link:calculationLink
999062 - Disclosure - Segments - Additional Information (Detail)
link:presentationLink
link:definitionLink
link:calculationLink
999063 - Disclosure - Segments (Parenthetical) (Detail)
link:presentationLink
link:definitionLink
link:calculationLink
999064 - Disclosure - Fair Value Measurement - Summary of Financial Items Carried at Fair Value (Detail)
link:presentationLink
link:definitionLink
link:calculationLink
999065 - Disclosure - Fair value measurement - Additional Information (Detail)
link:presentationLink
link:definitionLink
link:calculationLink
999066 - Disclosure - Fair Value Measurement - Summary of Fair Value of Financial Liabilities Measured Using Level 3 Inputs (Detail)
link:presentationLink
link:definitionLink
link:calculationLink
999067 - Disclosure - Fair Value Measurement - Summary of Financial Instrument Measured on a Basis Other Than Fair Value (Detail)
link:presentationLink
link:definitionLink
link:calculationLink
Cover [Abstract]
Document Period End Date
Document Period End Date
Entity Current Reporting Status
Entity Current Reporting Status
Entity Registrant Name
Entity Registrant Name
Entity Interactive Data Current
Entity Interactive Data Current
Entity Common Stock, Shares Outstanding
Entity Common Stock, Shares Outstanding
Entity File Number
Entity File Number
Entity Incorporation, State or Country Code
Entity Incorporation, State or Country Code
Entity Tax Identification Number
Entity Tax Identification Number
Entity Address, Address Line One
Entity Address, Address Line One
Entity Address, City or Town
Entity Address, City or Town
Entity Address, Postal Zip Code
Entity Address, Postal Zip Code
City Area Code
City Area Code
Local Phone Number
Local Phone Number
Document Transition Report
Document Transition Report
Entity Shell Company
Entity Shell Company
Entity Emerging Growth Company
Entity Emerging Growth Company
Entity Address, Country
Entity Address, Country
Title of 12(b) Security
Title of 12(b) Security
Trading Symbol
Trading Symbol
Security Exchange Name
Security Exchange Name
Document Type
Document Type
Entity Filer Category
Entity Filer Category
Amendment Flag
Amendment Flag
Document Fiscal Year Focus
Document Fiscal Year Focus
Document Fiscal Period Focus
Document Fiscal Period Focus
Entity Central Index Key
Entity Central Index Key
Current Fiscal Year End Date
Current Fiscal Year End Date
Entity Small Business
Smaller Reporting Company
Document Quarterly Report
Entity Address, Address Line Two
Statement of Financial Position [Abstract]
Statement [Table]
Statement [Table]
Legal Entity [Axis]
Legal Entity [Axis]
Entity [Domain]
Entity [Domain]
Statement [Line Items]
Statement [Line Items]
Assets [Abstract]
ASSETS
Assets, Current [Abstract]
Current assets:
Cash and Cash Equivalents, at Carrying Value
Cash and cash equivalents
Accounts Receivable, after Allowance for Credit Loss, Current
Accounts receivables, net of allowance for credit losses of $75 million and $81 million as of June 30, 2026 and December 31, 2025, respectively
Accounts receivables, net
Inventory, Net
Inventories
Total
Prepaid Expense, Current
Prepaid expenses
Other Assets, Current
Other current assets
Disposal Group, Including Discontinued Operation, Assets, Current
Assets held for sale
Total assets of the disposal group classified as held for sale in the consolidated balance sheets
Assets, Current
Total current assets
Deferred Income Tax Assets, Net
Deferred income taxes
Other Assets, Noncurrent
Other non-current assets
Property, Plant and Equipment, Net
Property, plant and equipment, net
Finite-Lived Intangible Assets, Net
Identifiable intangible assets, net
Net carrying amount
Goodwill
Goodwill
Beginning balance
Ending balance
Assets
Total assets
Operating Lease, Right-of-Use Asset
Operating lease right-of-use assets, net
Liabilities and Equity [Abstract]
LIABILITIES AND EQUITY
Liabilities, Current [Abstract]
Current liabilities:
Debt, Current
Short-term debt
Total short term debt
Sales Reserves And Allowances
Sales reserves and allowances
The sum of the balance sheet amounts of the allowances for chargebacks, returns, rebates, other promotional items and price protection.
Accounts Payable, Trade, Current
Accounts payables
Employee-related Liabilities, Current
Employee-related obligations
Accrued Expenses
Accrued expenses
Accrued expenses.
Other Liabilities, Current
Other current liabilities
Liabilities, Current
Total current liabilities
Liabilities Held For Sale Current
Liabilities held for sale
Liabilities held for sale current.
Liabilities, Noncurrent [Abstract]
Long-term liabilities:
Deferred Tax and Other Liabilities, Noncurrent
Deferred income taxes
Other Liabilities, Noncurrent
Other taxes and long-term liabilities
Notes and Loans, Noncurrent
Senior notes and loans
Total senior notes and loans
Liabilities, Noncurrent
Total long-term liabilities
Operating Lease, Liability, Noncurrent
Operating lease liabilities
Stockholders' Equity Attributable to Parent [Abstract]
Teva shareholders' equity:
Common Stock, Value, Issued
Ordinary shares of NIS 0.10 par value per share; June 30, 2026 and December 31, 2025: authorized 2,495 million shares; issued 1,271 million shares and 1,257 million shares, respectively.
Additional Paid in Capital
Additional paid-in capital
Retained Earnings (Accumulated Deficit)
Accumulated deficit
Accumulated Other Comprehensive Income (Loss), Net of Tax
Accumulated other comprehensive loss
Treasury Stock, Value
Treasury shares as of June 30, 2026 and December 31, 2025: 106 million ordinary shares and 107 million ordinary shares, respectively
Stockholders' Equity Attributable to Parent
Stockholders' equity attributable to Teva shareholders
Liabilities
Total liabilities
Stockholders' Equity Attributable to Noncontrolling Interest
Non-controlling interests
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
Total equity
Beginning balance
Ending balance
Liabilities and Equity
Total liabilities and equity
Common Stock, Par or Stated Value Per Share
Common stock, par or stated value per share
Common Stock, Shares Authorized
Ordinary shares, authorized
Common Stock, Shares, Issued
Ordinary shares, issued
Treasury Stock, Common, Shares
Treasury shares
Accounts Receivable, Allowance for Credit Loss, Current
Allowance for credit losses
Income Statement [Abstract]
Earnings Per Share [Abstract]
Earnings (loss) per share attributable to ordinary shareholders:
Earnings Per Share, Basic
Basic
Basic earnings (loss) attributable to Teva's ordinary shareholders
Earnings Per Share, Diluted
Diluted
Diluted earnings (loss) attributable to Teva's ordinary shareholders
Weighted Average Number of Shares Outstanding, Diluted [Abstract]
Weighted average number of shares (in millions):
Weighted Average Number of Shares Outstanding, Basic
Basic
Weighted average shares outstanding
Weighted Average Number of Shares Outstanding, Diluted
Diluted
Total dilutive shares outstanding
Revenue from Contract with Customer, Excluding Assessed Tax
Net revenues
Total revenue
Revenues
Cost of Goods and Services Sold
Cost of sales
Gross Profit
Gross profit
Research and Development Expense (Excluding Acquired in Process Cost)
Research and development expenses
R&D expenses
Selling and Marketing Expense
Selling and marketing expenses
S&M expenses
General and Administrative Expense
General and administrative expenses
G&A expenses
Intangible Assets Impairments
Intangible assets impairments
Intangible Assets Impairments
Other Operating Income (Expense), Net
Other loss (income)
Operating Income (Loss)
Operating income (loss)
Segment profit
Consolidated operating income (loss)
Nonoperating Income (Expense)
Financial expenses, net
Financial expenses, net
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest
Income (loss) before income taxes
Consolidated income (loss) before income taxes
Income Tax Expense (Benefit)
Income taxes (benefit)
Tax benefit
Income (Loss) from Equity Method Investments
Share in (profits) losses of associated companies, net
Share in (profits) losses of associated companies, net
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
Net income (loss)
Net income (loss)
Net Income (Loss) Attributable to Noncontrolling Interest
Net income (loss) attributable to redeemable and non-redeemable non-controlling interests
Net income (loss) attributable to Teva
Net income (loss)
Impairments Restructuring And Others
Other assets impairments, restructuring and other items
Other asset impairments, restructuring and other items
Impairments restructuring and others.
Legal Settlements And Loss Contingencies
Legal settlements and loss contingencies
The net proceeds or assets obtained in excess of (less than) the net carrying amount of assets recorded, or assets distributed and liabilities assumed less than (in excess of) litigation reserves extinguished, in settlement of a litigation matter. Represents (for other than an insurance entity in its normal claims settlement process), the amount of income (expense) recognized in the period to settle pending or threatened litigation and insurance claims and the aggregate amount provided for estimated restructuring charges, remediation costs, and asset impairment loss during an accounting period. Generally, these items are either unusual or infrequent, but not both (in which case they would be extraordinary items).
Statistical Measurement [Axis]
Range [Axis]
Statistical Measurement [Domain]
Range [Domain]
Minimum [Member]
Minimum [Member]
Statement of Comprehensive Income [Abstract]
Other Comprehensive Income (Loss), Net of Tax [Abstract]
Other comprehensive income (loss), net of tax:
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax
Currency translation adjustment
Unrealized gain (loss) on derivative net of tax
Unrealized gain (loss) from derivative financial instruments, net
Unrealized gain (loss) on derivative net of tax.
Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), after Tax
Unrealized loss on defined benefit plans
Other Comprehensive Income (Loss), Net of Tax
Total other comprehensive income (loss)
Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest
Total comprehensive income (loss)
Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest
Comprehensive income (loss) attributable to redeemable and non-redeemable non-controlling interests
Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive income (loss) attributable to Teva
Class of Stock [Axis]
Class of Stock [Domain]
Equity Components [Axis]
Equity Components [Axis]
Equity Component [Domain]
Equity Component [Domain]
Accounting Standards Update [Axis]
Accounting Standards Update [Domain]
Statement of Stockholders' Equity [Abstract]
Common Stock [Member]
Ordinary Shares [Member]
Additional Paid-in Capital [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
AOCI Attributable to Parent [Member]
Treasury Stock, Common [Member]
Treasury Shares [Member]
Parent [Member]
Total Teva shareholders' equity [Member]
Noncontrolling Interest [Member]
Non-controlling Interests [Member]
Shares, Issued
Beginning balance, shares
Ending balance, shares
Stock Issued During Period, Shares, New Issues
Issuance of Shares, shares
Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition
Stock-based compensation expense
Net Income Loss Including Noncontrolling Interest
Net income (loss)
Net income loss including noncontrolling interest.
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
Other comprehensive income (loss)
Net other comprehensive income (loss) after tax
Proceeds from Stock Options Exercised
Proceeds from exercise of options
Noncontrolling Interest, Increase from Subsidiary Equity Issuance
Purchase of shares from non-controlling interests
Maximum [Member]
Maximum [Member]
Stock Issued During Period, Value, Stock Options Exercised
Exercise of options by employees and vested RSUs
Statement of Cash Flows [Abstract]
Increase (Decrease) in Operating Capital [Abstract]
Net change in operating assets and liabilities:
Increase (Decrease) in Other Current Assets
Other assets
Increase Decrease In Certain Current Liabilities Excluding Debt
Trade payables, accrued expenses, employee-related obligations and other liabilities
Increase decrease in certain current liabilities excluding debt.
Increase Decrease In Certain Current Assets Excluding Inventories
Trade receivables net of sales reserves and allowances
Increase decrease in certain current assets excluding inventories.
Increase (Decrease) in Inventories
Inventories
Net Change In Items Comprising Supplemental Disclosure Of Cash Flow Information
Net Change In Items Comprising Supplemental Disclosure Of Cash Flow Information
The net change during the reporting period in the amounts of the current assets and current liabilities that are reported in the supplemental disclosure of information section of the Consolidated Statements of Cash Flows.
Net Cash Provided by (Used in) Financing Activities [Abstract]
Financing activities:
Repayments of Other Long-Term Debt
Repayment of senior notes and loans and other long-term liabilities
Proceeds from (Payments for) Other Financing Activities
Other financing activities
Net Cash Provided by (Used in) Financing Activities
Net cash provided by (used in) financing activities
Repayments Of Convertible Debentures
Repayment of convertible debentures
Repayments of convertible debentures.
Dividends Paid To Non controlling Interests
Dividends paid to redeemable and non-redeemable non-controlling interests
Dividends paid to noncontrolling interests.
Proceed From Minority Non Controlling Shareholders
Purchase of shares from redeemable and non-redeemable non-controlling interests
Proceed from Minority Non-Controlling Shareholders.
Net Cash Provided by (Used in) Investing Activities [Abstract]
Investing activities:
Payment To Acquire Marketable Securities And Other Assets
Purchases of investments and other assets
The cash outflow from purchase of available for sales securities and other assets.
Payments for (Proceeds from) Other Investing Activities
Other investing activities
Net Cash Provided by (Used in) Investing Activities
Net cash provided by (used in) investing activities
Proceeds from Divestiture of Businesses
Proceeds from sale of business and long-lived assets, net
Payments to Acquire Equity Securities, FV-NI
Purchase of Emalex Biosciences outstanding shares, see note 2
Proceeds From Beneficial Interest In Exchange For Securitized Accounts Receivables
Beneficial interest collected in exchange for securitized trade receivables
Proceeds from beneficial interest in exchange for securitized accounts receivables.
Payments to Acquire Productive Assets
Purchases of property, plant and equipment and intangible assets
Net Cash Provided by (Used in) Operating Activities [Abstract]
Operating activities:
Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]
Adjustments to reconcile net income (loss) to net cash provided by operations:
Impairment Of Long Lived Assets And Assets Held For Sale Finite And Indefinite Lived Intangible Assets Other Than Goodwill
Impairment of long-lived assets and assets held for sale
Impairment of long lived assets and assets held for sale finite and indefinite lived intangible assets other than goodwill.
Depreciation, Depletion and Amortization, Nonproduction
Depreciation and amortization
Increase (Decrease) in Operating Capital
Net change in operating assets and liabilities
Deferred Income Taxes Net And Uncertain Tax Positions
Deferred income taxes – net and uncertain tax positions
Deferred income taxes net and uncertain tax positions.
Profit From Sale Of Long Lived Assets And Investment
Net loss (gain) from sale of business and long-lived assets
Profit from sale of long lived assets and investment.
Share-based Compensation
Stock-based compensation
Other Operating Activities, Cash Flow Statement
Other items
Research And Development Expense And Liabilities
Acquired IPR&D related to Emalex Biosciences, see note 2
Research and development expense and liabilities.
Net Cash Provided by (Used in) Operating Activities
Net cash provided by (used in) operating activities
Supplemental Cash Flow Information [Abstract]
Non-cash financing and investing activities:
Beneficial Interest Obtained in Exchange for Securitized Accounts Receivables
Beneficial interest obtained in exchange for securitized accounts receivables
Beneficial interest obtained in exchange for securitized accounts receivables.
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
Effect of exchange rate changes on cash and cash equivalents
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect
Net change in cash and cash equivalents
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
Balance of cash and cash equivalents at beginning of period
Balance of cash and cash equivalents at end of period
Dividends [Axis]
Dividends [Domain]
Brian P. Savage, Interim Chief Legal Officer [Member]
Evan Lippman, EVP, Business Development [Member]
Richard D. Francis, President and CEO [Member]
Basis of Presentation [Abstract]
Basis of Presentation [Table]
Basis of Presentation and Significant Accounting Policies [Text Block]
Basis of presentation
Text Block [Abstract]
Certain Transactions [Table]
Certain Transactions Disclosure [Text Block]
Certain transactions
This element may be used for the entire related party transactions disclosure as a single block of text. Disclosure may include: business acquisitions, agreements with related parties, significant cooperation agreements, the nature of the relationship(s), a description of the transactions, the amount of the transactions, the effects of any change in the method of establishing the terms of the transaction from the previous period, stated interest rate, expiration date, terms and manner of settlement per the agreement with the related party, and amounts due to or from related parties. If the entity and one or more other entities are under common ownership or management control and this control affects the operating results or financial position, disclosure includes the nature of the control relationship even if there are no transactions between the entities. Disclosure may also include the aggregate amount of current and deferred tax expense for each statement of earnings presented where the entity is a member of a group that files a consolidated tax return, the amount of any tax related balances due to or from affiliates as of the date of each statement of financial position presented, the principal provisions of the method by which the consolidated amount of current and deferred tax expense is allocated to the members of the group and the nature and effect of any changes in that method. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue [Table]
Disaggregation of Revenue [Table]
Revenue from Contract with Customer [Text Block]
Revenue from contracts with customers
Inventory Disclosure [Abstract]
Inventory, Current [Table]
Inventory Disclosure [Text Block]
Inventories
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets Disclosure [Table]
Intangible Assets Disclosure [Text Block]
Identifiable intangible assets
Goodwill Disclosure [Text Block]
Goodwill
Debt Disclosure [Abstract]
Debt Obligations [Table]
Debt Disclosure [Text Block]
Debt obligations
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments and Hedging Activities Disclosure [Text Block]
Derivative Instruments and Hedging Activities
Commitments and Contingencies Disclosure [Abstract]
Legal Matters and Contingencies [Text Block]
Legal Settlements and Loss Contingencies
Commitments and Contingencies Disclosure [Text Block]
Commitments and contingencies
Income Tax Disclosure [Abstract]
Income Tax Disclosure [Text Block]
Income taxes
Other Expenses [Text Block]
Other assets impairments, restructuring and other items
Other Expenses [Text Block]
Earnings Per Share [Text Block]
Earnings (Loss) per share
Equity [Abstract]
Stockholders' Equity Note Disclosure [Text Block]
Accumulated other comprehensive income (loss)
Segment Reporting [Abstract]
Segment Reporting Disclosure [Text Block]
Segments
Fair Value Disclosures [Abstract]
Fair Value Measurement [Table]
Fair Value Disclosures [Text Block]
Fair value measurement
Schedule Of Assets And Liabilities Held For Sale [Table Text Block]
Summary of Major Classes of Assets and Liabilities Included as Held for Sale
Schedule Of Assets And Liabilities Held For Sale [Table Text Block]
Asset Acquisition [Table Text Block]
Summary of Assets Acquired, liabilities Assumed
Disaggregation of Revenue [Table Text Block]
Summary of disaggregates revenues by major revenue streams
Sales Reserves And Allowances Current [Table Text Block]
Summary of Sales Reserves and Allowances
Tabular disclosure of sales reserves and allowances current.
Schedule of Inventory, Current [Table Text Block]
Summary of Inventories
Schedule of Finite-Lived Intangible Assets [Table Text Block]
Summary of Identifiable Intangible Assets
Schedule of Goodwill [Table Text Block]
Summary of Changes in the Carrying Amount of Goodwill by Segment
Schedule of Short-term Debt [Table Text Block]
Schedule of Short-term Debt
Long Term Debt Excluding Convertible Debt Table [Text Block]
Schedule of Long-term debt
A schedule of data and information pertaining to long-debt instruments or arrangements, excluding convertible debt, that includes identification, terms, features, collateral requirements and other information necessary to a fair presentation.
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]
Summary of Classification and Fair Values of Derivative Instruments
Derivatives Not Designated as Hedging Instruments [Table Text Block]
Summary of Pre-tax (Gains) Losses From Derivatives Not Designated in as Hedging Instruments
Disclosure In Tabular Form Of Pretax Gain Loss Cash Flow Hedging Instruments [Table Text Block]
Summary of Pre-tax (Gains) Losses From Derivatives Designated in Cash Flow Hedging Relationships
Disclosure in tabular form of pretax gain loss cash flow hedging instruments.
Schedule of Restructuring Reserve by Type of Cost [Table Text Block]
Schedule of Other Assets Impairments, Restructuring and Other Items
Schedule of Restructuring Charges [Table Text Block]
Summary of Restructuring Plan Including Costs Related to Exit and Disposal
Schedule of Restructuring Charges [Table Text Block]
Restructuring and Related Costs [Table Text Block]
Summary of Restructuring Accruals
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
Schedule of Earnings per Share
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]
Accumulated Other Comprehensive Income/(Loss) (Net of Tax)
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]
Summary of Segment Profit
Schedule Of Consolidated Income Before Income Tax [Table Text Block]
Schedule Of Consolidated Income Before Income Tax
Schedule of consolidated income before income tax.
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]
Summary of Financial Items Carried at Fair Value
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]
Summary of Fair Value of Financial Liabilities Measured Using Level 3 Inputs
Fair Value, Assets Measured on Recurring and Nonrecurring Basis [Table Text Block]
Summary of Financial Instrument Measured on a Basis Other Than Fair Value
Business Combination, Consideration Transferred [Abstract]
Noncash or Part Noncash Acquisitions [Table]
Noncash or Part Noncash Acquisitions [Table]
Business Combination [Axis]
Business Acquisition [Axis]
Business Combination [Domain]
Business Acquisition, Acquiree [Domain]
Modag [Member]
MODAG [Member]
Modag .
MedinCell [Member]
MedinCell [ Member].
Polpharma [Member]
Emalex Biosciences [Member]
Blackstone Life Sciences [Member]
Blackstone Life Sciences [Member]
Tevas API Business [Member]
Teva's API business [Member]
Teva's API business.
Abingworth [Member]
Alvotech [Member]
Alvotech.
mAbxience [Member]
mAbxience.
Royalty Pharma [Member]
Royalty Pharma [Member]
Royalty pharma.
Biolojic Design Ltd [Member]
Biolojic Design Ltd [Member]
Biolojic design ltd.
Counterparty Name [Axis]
Counterparty Name [Axis]
Counterparty Name [Domain]
Counterparty Name [Domain]
Sanofi [Member]
Sanofi [Member]
Sanofi.
Noncash or Part Noncash Acquisitions [Line Items]
Noncash or Part Noncash Acquisitions [Line Items]
Payments to Acquire Businesses, Gross
Cash consideration
Collaborative Agreement Milestone Payments
Collaborative agreement milestone payments
Collaborative Agreement Milestone Payments
Milestone Payment
Milestone payment
Milestone payment.
License Agreement Potential Aggregate Milestone Payments Amount
License agreement potential aggregate milestone payments amount
License agreement potential aggregate milestone payments amount.
Percentage Of Discount Rate Applied To The Cash Flows
Percentage of discount rate applied to the cash flows.
Collaboration Partner Funding Reimbursements
Collaboration partner funding reimbursements
Collaboration partner funding reimbursements.
Agreement Milestone Payments
Agreement Milestone Payments
Agreement milestone payments.
Increase in development funding commitment
Increase in development funding commitment
Increase in development funding commitment.
Milestone Payment To Be Paid
Milestone payment to be paid.
MilestonePaymentPercentageCap
Milestone payment percentage cap
Milestone payment percentage cap.
Phase3FundingOptionAmount
Phase 3 funding option amount
Phase 3 funding option amount.
Phase2bFundingOptionAmount
Phase 2b funding option amount
Phase 2b funding option amount.
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, before Tax
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, before Tax
Aggregate Upfront And Milestone Payments
Aggregate upfront and milestone payments
Aggregate Upfront And Milestone Payments.
Term Of Royalty Payment
Term of royalty payment
Term of royalty payment.
Other Commitment
Other commitment
Research and Development Arrangement, Contract to Perform for Others, Compensation Earned
Reimbursement of research and development expenses incurred
Additional Development And Milestone Payments Receivable
Additional development and milestone payments receivable
Additional development and milestone payments receivable.
Development and Launch Milestone Payment Receivable
Development and launch milestone payment receivable
Development and launch milestone payment receivable.
Milestone Payment Receivable
Milestone payment receivable
Milestone payment receivable.
Statement of Income Location, Balance [Axis]
Income Statement Location [Axis]
Statement of Income Location, Balance [Domain]
Income Statement Location [Domain]
Research and Development Expense [Member]
Lease Contractual Term [Axis]
Lease Contractual Term [Axis]
Lease Contractual Term [Domain]
Lease Contractual Term [Domain]
Subsequent Event Type [Axis]
Subsequent Event Type [Domain]
Subsequent Event [Member]
Consideration Arrangement [Axis]
Consideration Arrangement [Domain]
Other Third Parties Milestone Payment [Member]
Former Shareholders Milestone Payment [Member]
Agreement [Axis]
Agreement.
Agreement [Domain]
Agreement.
Debt Instrument [Axis]
Debt Instrument [Axis]
Debt Instrument, Name [Domain]
Debt Instrument, Name [Domain]
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Collaborative Arrangement and Arrangement Other than Collaborative [Domain]
Collaborative Arrangement [Member]
Collaborative Arrangement [Member]
Asset Acquisition [Abstract]
Asset Acquisition [Table]
Asset Acquisition [Axis]
Asset Acquisition [Domain]
Asset Acquisition [Line Items]
Asset Acquisition Acquired IPR and D
Acquired IPR&D
Asset acquisition acquired ipr and d.
Asset Acquisition Identifiable Assets And Liabilities Acquired Net
Total identifiable assets and liabilities acquired
Asset acquisition identifiable assets and liabilities acquired net.
Asset Acquisition Consideration Transferred Other Liabilities
Other liabilities
Asset acquisition consideration transferred other liabilities.
Asset Acquisition Consideration Transferred Accrued Expenses
Accrued expenses
Asset acquisition consideration transferred accrued expenses.
Asset Acquisition Consideration Transferred Valuation Allowance
Valuation allowance
Asset acquisition consideration transferred valuation allowance.
Asset Acquisition Consideration Transferred Deferred Income Taxes
Deferred income taxes
Asset acquisition consideration transferred deferred income taxes.
Asset Acquisition, Consideration Transferred, Other Assets
Other current assets
Asset Acquisition, Consideration Transferred
Total consideration allocated
Asset Acquisition, Consideration Transferred, Transaction Cost
Transaction costs
Asset Acquisition Consideration Transferred Cash
Cash consideration for outstanding shares, net of working capital adjustments
Asset acquisition consideration transferred cash.
Business Combinations [Abstract]
Disposal Group, Including Discontinued Operation, Inventory, Current
Inventories
Disposal Group, Including Discontinued Operation, Property, Plant and Equipment, Current
Property, plant and equipment, net
Disposal Group, Including Discontinued Operation, Goodwill, Current
Goodwill
Assets, Fair Value Adjustment
Expected loss on sale
Disposal Group, Including Discontinued Operation, Liabilities
Total liabilities of the disposal group classified as held for sale in the consolidated balance sheets
Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent
Other non-current liabilities
Disposal Group, Including Discontinued Operation, Other Assets, Noncurrent
Other non-current assets
Disposal Group, Including Discontinued Operation, Liabilities, Current
Other current liabilities
Disposal Group, Including Discontinued Operation, Accounts Payable
Accounts payables
Disposal Group, Including Discontinued Operation, Other Assets, Current
Other current assets
Disposal Group, Including Discontinued Operation, Intangible Assets, Current
Identifiable intangible assets, net
Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net
Accounts receivables
Revenue Recognition [Abstract]
Revenue Recognition [Table]
Revenue Recognition [Table]
Revenue Recognition [Table]
Revenue Recognition [Line Items]
Revenue Recognition [Line Items]
Revenue Recognition [Line Items]
Sales Reserves and Allowances to Customers Percentage
Percentage sales reserves and allowances to U.S. customers
Sales reserves and allowances to customers percentage.
Geographical [Axis]
Geographical [Axis]
Geographical [Domain]
Geographical [Domain]
UNITED STATES
United States [Member]
Factoring Institution [Axis]
Factoring institution.
Factoring Institution [Domain]
Factoring institution.
Derivative Instrument [Axis]
Derivative Instrument [Axis]
Derivative Contract [Domain]
Derivative Contract [Domain]
Pledging Purpose [Axis]
Pledging Purpose [Domain]
Disaggregation of Revenue [Abstract]
Disaggregation of Revenue [Line Items]
Disaggregation of Revenue [Line Items]
Product and Service [Axis]
Product and Service [Axis]
Product and Service [Domain]
Product and Service [Domain]
Product [Member]
Sale of Goods [Member]
License [Member]
Licensing Arrangements [Member]
Distribution Service [Member]
Distribution [Member]
Product and Service, Other [Member]
Other [Member]
Segments [Axis]
Segments [Axis]
Segments [Domain]
Segments [Domain]
International Markets [Member]
International Markets [Member]
International markets.
Other Activities [Member]
Other Activities [Member]
Europe [Member]
Europe [Member]
SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount
Balance at beginning of period
Balance at end of period
Valuation Allowances And Reserves Related To Current Period Sales
Provisions related to sales made in current year period
Valuation allowances and reserves related to current period sales.
Valuation Allowances And Reserves Related To Prior Period Sales
Provisions related to sales made in prior periods
Valuation allowances and reserves related to prior period sales.
SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction
Credits and payments
Valuation Allowances And Reserves Foreign Currency Translation
Translation differences
Valuation allowances and reserves foreign currency translation.
SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]
SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]
SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]
SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]
Reserves Included In Accounts Receivable Net [Member]
Reserves Included in Accounts Receivable, net [Member]
Reserves included in accounts receivable net.
Rebates [Member]
Rebates [Member]
Rebates.
Medicaid And Other Governmental Allowances [Member]
Medicaid and other governmental allowances [Member]
Medicaid and other governmental allowances.
Chargebacks [Member]
Chargebacks [Member]
Chargebacks.
Returns [Member]
Returns [Member]
Returns.
Other Sales Reserves And Allowances [Member]
Other [Member]
Other sales reserves and allowances.
Total Reserves Included In Sales Reserves And Allowances [Member]
Total reserves included in sales reserves and allowances [Member]
Total reserves included in sales reserves and allowances.
Inventories [Table]
Inventories [Table]
Inventories [Table]
Inventories [Line Items]
Inventories [Line Items]
Inventories [Line Items]
Inventory, Finished Goods, Net of Reserves
Finished products
Inventory, Raw Materials, Net of Reserves
Raw and packaging materials
Inventory, Work in Process, Net of Reserves
Products in process
Other Inventory, in Transit, Gross
Materials in transit and payments on account
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Schedule of Finite-Lived Intangible Assets [Table]
Schedule of Finite-Lived Intangible Assets [Table]
Finite-Lived Intangible Assets by Major Class [Axis]
Finite-Lived Intangible Assets by Major Class [Axis]
Finite-Lived Intangible Assets, Major Class Name [Domain]
Finite-Lived Intangible Assets, Major Class Name [Domain]
In Process Research and Development [Member]
In process research and development [Member]
In process research and development [Member]
Product Rights [Member]
Identifiable product rights [Member]
Product rights [Member]
Product Rights [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets [Line Items]
Amortization of Intangible Assets
Amortization of intangible assets
Impairment of Intangible Assets (Excluding Goodwill)
Impairment of intangible assets excluding goodwill
Business Combination, Contingent Consideration, Liability, Measurement Input
Business combination, contingent consideration, liability, measurement input
Impairment, Intangible Asset, Statement of Income or Comprehensive Income [Extensible Enumeration]
Finite-Lived Intangible Asset, Useful Life
Amortization of intangible assets useful life
Generic Pipeline Products [Member]
Discontinuation Of Business [Axis]
Discontinuation Of Business [Domain]
Measurement Input Type [Axis]
Measurement Input Type [Domain]
Measurement Input, Discount Rate [Member]
Measurement input, discount rate [Member]
Impairment Of Intangible Assets Reasons For Impairment [Axis]
Impairment Of Intangible Assets Reasons For Impairment.
Impairment Of Intangible Assets Reasons For Impairment [Domain]
Impairment Of Intangible Assets Reasons For Impairment.
Reclassification, Type [Axis]
Reclassification, Type [Domain]
In Process Research And Development To Product Rights [Member]
In Process Research And Development To Product Rights [Member]
In Process Research And Development To Product Rights [Member]
Event Basis [Axis]
Event basis .
Event Basis [Domain]
Event basis .
Development Progress And Changes In Other Key Valuation Assumptions [Member]
Development Progress And Changes In Other Key Valuation Assumptions [Member]
Development progress and changes in other key valuation assumptions.
Regulatory Price And Volume Of Products [Member]
Regulatory Price And Volume Of Products [Member]
Regulatory price and volume of products.
Updated Market Assumptions [Member]
Updated Market Assumptions [Member]
Updated market assumptions .
Trade Names [Member]
Trade names [Member]
Finite-Lived Intangible Assets, Gross
Gross carrying amount net of impairment
Finite-Lived Intangible Assets, Accumulated Amortization
Accumulated amortization
Goodwill [Roll Forward]
Schedule of Goodwill [Table]
Schedule of Goodwill [Table]
Goodwill [Line Items]
Goodwill [Line Items]
Goodwill, Foreign Currency Translation Gain (Loss)
Translation differences and other
Good will Relative Fair Value Allocation
Goodwill allocation related to the shift of Anda to Other Activities
Good will Relative Fair Value Allocation.
Other Countries [Member]
Other [Member]
Other countries.
Consolidation Items [Axis]
Consolidation Items [Domain]
Subsegments [Axis]
Subsegments [Domain]
Goodwill, Impaired, Accumulated Impairment Loss
Accumulated goodwill impairment
Reporting Unit [Axis]
Reporting Unit [Domain]
Schedule of Long-term Debt Instruments [Table]
Schedule of Long-term Debt Instruments [Table]
Currency [Axis]
Currency [Axis]
All Currencies [Domain]
All Currencies [Domain]
Short Credit Agreement 2026 [Member]
Convertible senior debentures [Member]
Short credit agreement 2026.
Debt Instrument [Line Items]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Effective Percentage
Weighted average interest rate
Weighted average interest rate
Debt Instrument Maturity Year
Maturity
Debt Instrument Maturity Year
Short-term Debt
Convertible debentures
Long-term Debt, Current Maturities
Current maturities of long-term liabilities
Variable Rate [Axis]
Variable Rate [Axis]
Variable Rate [Domain]
Variable Rate [Domain]
Credit Facility [Axis]
Credit Facility [Axis]
Credit Facility [Domain]
Credit Facility [Domain]
Short-Term Debt, Weighted Average Interest Rate, at Point in Time
Weighted average interest rate
Repayments of Short-Term Debt
Repayments of convertible senior debentures
Short-Term Debt, Type [Axis]
Short-Term Debt, Type [Domain]
Short-term Debt, Type [Domain]
Convertible Debt [Member]
Senior notes USD 500 million [Member]
Senior notes EUR 1000 Million [Member]
Senior notes USD 700 million [Member]
Subsidiary Senior Notes Due 2046 [Member]
Senior notes USD 2,000 million [Member]
Subsidiary senior notes due 2046.
Subsidiary Senior Notes Due 2036 [Member]
Senior notes USD 789 million [Member]
Subsidiary senior notes due 2036.
Sustainability Linked Senior Notes Due 2031 One [Member]
Sustainability-linked senior notes EUR 500 million [Member]
Sustainability linked senior notes due 2031 one.
Sustainability Linked Senior Notes Due 2031 [Member]
Sustainability-linked senior notes USD 500 million [Member]
sustainability linked senior notes due 2031.
Sustainability Linked Senior Notes Due 2030 [Member]
Sustainability-linked senior notes EUR 1,500 million [Member]
Sustainability-linked senior notes EUR 1,500 million [Member]
Sustainability linked senior notes due 2030.
Sustainability Linked Senior Notes Due 2029 Two [Member]
Sustainability-linked senior notes EUR 800 million [Member]
Sustainability-linked senior notes EUR 800 million [Member]
Sustainability linked senior notes due 2029 two.
Sustainability Linked Senior Notes Due 2029 One [Member]
Sustainability-linked senior notes USD 600 million [Member]
Sustainability-linked senior notes USD 600 million [Member]
Sustainability linked senior notes due 2029 one.
Sustainability Linked Senior Notes Due 2029 [Member]
Sustainability-linked senior notes USD 1,000 million [Member]
Sustainability-linked senior notes USD 1,000 million [Member]
Sustainability linked senior notes due 2029.
Subsidiary Senior Notes Due 2028 One [Member]
Senior notes EUR 750 million [Member]
Subsidiary Senior Notes Due 2028 One [Member]
Subsidiary Senior Notes Due 2028 [Member]
Senior notes USD 1,250 million [Member]
Subsidiary senior notes due 2028.
Sustainability Linked Senior Notes Due 2027 One [Member]
Sustainability-linked senior notes EUR 1,100 million [Member]
Sustainability linked senior notes due 2027 one.
Sustainability Linked Senior Notes Due 2027 [Member]
Sustainability-linked senior notes USD 1,000 million [Member]
Sustainability linked senior notes due 2027.
Subsidiary Senior Notes Due 2027 [Member]
Senior notes EUR 700 million [Member]
Subsidiary senior notes due 2027.
Subsidiary Senior Notes Due 2026 [Member]
Senior notes USD 3,500 million [Member]
subsidiary senior notes due 2026.
Senior Notes
Total senior notes
Senior Notes, Current
Less current maturities
Debt Issuance Costs, Noncurrent, Net
Less debt issuance costs
Debt Instrument, Face Amount
Debt instrument face amount
Hedging Designation [Axis]
Hedging Designation [Axis]
Hedging Designation [Domain]
Hedging Designation [Domain]
Period From Which Interest Rate Increase Could Be Applicable [Axis]
Period From Which Interest Rate Increase Could Be Applicable.
Period From Which Interest Rate Increase Could Be Applicable [Domain]
Period From Which Interest Rate Increase Could Be Applicable.
Long-term Debt, Type [Axis]
Long-term Debt, Type [Axis]
Long-term Debt, Type [Domain]
Long-term Debt, Type [Domain]
Revolving Credit Facility [Member]
Revolving Credit Facility [Member]
Amended Revolving Credit Facility [Member]
Amended revolving credit facility member.
Long Term Debt Currency Portion U S D
Long term debt currency portion USD
Long term debt currency portion U S D.
Line of Credit Facility, Maximum Borrowing Capacity
Leverage Ratio
Leverage Ratio
Leverage ratio.
Tranche [Axis]
Tranche.
Tranche [Domain]
Tranche.
Lender Name [Axis]
Line of Credit Facility, Lender [Domain]
Period [Axis]
Period axsis.
Period [Domain]
Period domain.
Derivative Instrument Detail [Abstract]
Derivative [Table]
Derivative [Table]
Balance Sheet Location [Axis]
Balance Sheet Location [Axis]
Balance Sheet Location [Domain]
Balance Sheet Location [Domain]
Other Current Liabilities [Member]
Other Current Liabilities [Member]
Other Current Assets [Member]
Other Noncurrent Liabilities [Member]
Foreign Exchange Contract [Member]
Foreign Exchange Contract [Member]
Cross Currency Swap Cash Flow Hedge [Member]
Cross Currency Swap Cash Flow Hedge.
Hedging Relationship [Axis]
Hedging Relationship [Axis]
Hedging Relationship [Domain]
Hedging Relationship [Domain]
Derivative [Line Items]
Derivative [Line Items]
Derivative Asset, Fair Value, Gross Asset
Asset derivatives
Derivative Liability, Fair Value, Gross Liability
Liability derivatives
Designated as Hedging Instrument [Member]
Designated as Hedging Instrument [Member]
Not Designated as Hedging Instrument [Member]
Not Designated as Hedging Instrument [Member]
Unrealized Gain (Loss) on Cash Flow Hedging Instrument
Financial expenses, net
Unrealized gain (loss) on cash flow hedging instrument.
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax, Parent
Other comprehensive income (loss)
Financial expenses [Member]
Financial expenses [Member]
Other Comprehensive Income Location [Axis]
Other Comprehensive Income Location [Domain]
Other Comprehensive Income (Loss) [Member]
Other Comprehensive Income [Member]
Gain (Loss) on Derivative Instruments, Net, Pretax
Gain (Loss) on Derivative Instruments, Net, Pretax
Net Revenues [Member]
Net Revenues [Member]
Not Designated as Hedging Instrument, Trading [Member]
Not Designated as Hedging Instrument, Trading [Member]
Not Designated as Hedging Instrument, Economic Hedge [Member]
Not Designated as Hedging Instrument, Economic Hedge [Member]
Cross Currency Interest Rate Contract [Member]
Accounts Receivable [Member]
Accounts Receivable Securitization Facility [Member]
Accounts Receivable Securitization Facility [Member]
Accounts receivable securitization facility.
Revenues Other Than Usd
Revenues other than USD
Revenues other than US Dollar.
Transactions Termination Loss Settled
Transactions termination loss settled
Transactions termination loss settled.
Forward Starting Interest Rate Swaps And Treasury Lock Agreements Losses
Forward starting interest rate swaps and treasury lock agreements losses
Forward starting interest rate swaps and treasury lock agreements losses.
Debt, Weighted Average Interest Rate
Debt, weighted average interest rate
Supplier Finance Program, Obligation, Statement of Financial Position [Extensible Enumeration]
Supplier Finance Program, Obligation
Supplier finance program obligation
Derivative, Notional Amount
Derivative notional amount
Derivative, Term of Contract
Derivatives term of contract
Facility [Axis]
Facility.
Facility [Domain]
Facility.
Initial Commitment [Member]
Initial Commitment.
Five Point Seven Five Senior Notes Due 2030 [Member]
5.75% senior notes due 2030 [Member]
5.75% senior notes due 2030.
SPV Amendment Agreement October Two Thousand And Twenty Four [Member]
PNC Bank [Member]
PNC bank.
November Two Thousand And Twenty Three [Member]
November 2023 [Member]
Loss Contingencies [Table]
Loss Contingencies [Table]
Loss Contingencies [Line Items]
Loss Contingencies [Line Items]
Litigation Settlement, Expense
Legal settlements and loss contingencies, expenses
Loss Contingency Accrual
Accrued amount for legal settlements and loss contingencies
Generic modafinil, and imposed fines amount
Restructuring expense and income
Restructuring expense and income
Restructuring expense and income
Litigation Case [Axis]
Litigation Case [Domain]
Opioid Litigation [Member]
Commitment And Contingencies [Table]
Commitment And Contingencies [Table]
Commitment And Contingencies [Table]
Commitment And Contingencies [Line Items]
Commitment And Contingencies [Line Items]
Commitment And Contingencies [Line Items]
Annual Sales Of Effexor
Annual sales of Effexor
Annual sales of effexor.
Annual Sales Of Lamictal
Annual sales of Lamictal
Annual sales of Lamictal.
Annual Sales Of Niaspan
Annual sales of Niaspan
Annual sales of Niaspan.
Litigation Settlement, Amount Awarded to Other Party
Litigation settlement amount
Litigation Settlement Amount Awarded Distribution Period
Litigation settlement amount awarded distribution period
Litigation settlement amount awarded distribution period.
Loss Contingency Accrual, Provision
Loss Contingency Accrual, Provision
Annual Sales Of The Time Of Settlement Of Truvada
Annual sales of the time of settlement of Truvada
Annual sales of the time of settlement of truvada.
Annual Sales Of The Time Of Settlement Of Atripla
Annual sales of the time of settlement of Atripla
Annual sales of the time of settlement of atripla.
Annual Sales Of The Time Of New Launch Of Truvada
Annual sales of the time of New launch of Truvada
Annual sales of the time of New launch of truvada.
Annual Sales Of The Time Of New Launch Of Atripla
Annual sales of the time of New launch of Atripla
Annual sales of the time of new launch of Atripla.
Litigation Settlement Amount DistributableIn Kind
Litigation Settlement Amount Distributable In Kind
Litigation settlement amount distributableIn kind.
Accrual for Environmental Loss Contingencies
Accrual for Environmental Loss Contingencies
Loss Contingencies On Environmental Laws Penalty
Loss Contingencies On Environmental Laws Penalty
Loss contingencies on environmental laws penalty.
Annual Sales Of Xifaxan
Annual sales of Xifaxan
Annual Sales Of Xifaxan
Commission Surety Underwritten Guarantees
Commission surety underwritten guarantees
Commission Surety Underwritten Guarantees
Litigation Fine Amount Of Copaxone
Litigation fine amount of copaxone
Litigation fine amount of copaxone.
Settlement As A Percentage Of Aggregate Subdivisions And Tribes
Settlement as a percentage of aggregate subdivisions and tribes
Settlement as a percentage of aggregate subdivisions and tribes.
Loss Contingency Accrual Due In Fifth Year
Loss contingency accrual due in fifth year
Loss contingency accrual due in fifth year.
Loss Contingency Accrual Due In Fourth Year
Loss contingency accrual due in fourth year
Loss contingency accrual due in fourth year.
Loss Contingency Accrual Due In Year Three
Loss contingency accrual due in third year
Loss contingency accrual due in year three.
Loss Contingency Accrual Next Twelve Months
Loss contingency accrual next twelve months
Loss contingency accrual next twelve months.
Loss Contingency Accrual Remainder Of Fiscal Year
Loss contingency accrual remainder of fiscal year
Loss contingency accrual remainder of fiscal year.
Loss Contingency, Accrual, Current
Loss contingency accrual current
Loss Contingency Aggregate Payments Paid
Loss contingency aggregate payments paid
Loss contingency aggregate payments paid.
Loss Contingency Accrual, Product Liability, Undiscounted, to be Paid, Year Five
Loss contingency accrual, product liability, undiscounted, to be paid, year five
Loss Contingency Accrual, Product Liability, Undiscounted, to be Paid, Year Four
Loss contingency accrual, product liability, undiscounted, to be paid, year four
Loss Contingency Accrual, Product Liability, Undiscounted, to be Paid, Year Three
Loss contingency accrual, product liability, undiscounted, to be paid, year three
Loss Contingency Accrual, Product Liability, Undiscounted, to be Paid, Year Two
Loss contingency accrual, product liability, undiscounted, to be paid, year two
Loss Contingency Accrual, Product Liability, Undiscounted, to be Paid, Year One
Loss contingency accrual, product liability, undiscounted, to be paid, year one
Other Commitment, to be Paid, Year Five
Other commitment, to be paid, year five
Other Commitment to Pay for Each Year
Other commitment to pay for each year
Other commitment to pay for each year.
Annual Sales Of Revlimid
Annual Sales Of Revlimid
Annual sales of revlimid.
Annual Sales At The Time Of Nuvigil Entered Into First Settlement Of With AN ANDA Filer
Annual Sales At The Time Of Nuvigil Entered Into First Settlement Of With AN ANDA Filer
Annual sales at The time of nuvigil entered into first settlement of with AN ANDA hiler.
Loss Contingency Claims Dismissed Value Paid To Each State Proportional To Its Share Of National Population
Loss Contingency Claims Dismissed Value Paid To Each State Proportional To Its Share Of National Population
Loss contingency claims dismissed value paid to each state proportional to its share of national population
Percentage Of Share Of The National Population
Percentage Of Share Of The National Population
Percentage of share of the national population.
Litigation settlement amount payable in cash percentage
Percentgae of amount in cash settlement
Litigation settlement amount payable in cash percentage
Litigation Settlement Amount Distributable in Cash
Litigation Settlement Amount Distributable in cash
Litigation settlement amount distributable in cash.
Loss Contingency, Damages Awarded, Value
Loss Contingency, Damages Awarded, Value
Loss Contingency Nature [Axis]
Loss Contingency Nature [Axis]
Loss Contingency, Nature [Domain]
Loss Contingency, Nature [Domain]
Modafinil Settlement Agreement [Member]
Modafinil settlement agreement.
Civil Action In Respect Of Donations To Patient Assistance Programmers [Member]
Civil Action In Respect Of Donations To Patient Assistance Programmers [Member]
Civil action in respect of donations to patient assistance programmers.
Civil Investigative Demand From Department Of Justice Civil Division [Member]
Civil Investigative Demand From Department Of Justice Civil Division [Member]
Civil investigative demand from department of justice civil division.
Ontario Teachers Securities Litigation [Member]
Ontario teachers securities litigation.
Defendants [Axis]
Defendants.
Defendants [Member]
Defendants.
Deferred Prosecution Agreement With U.S. Department of Justice [Member]
Deferred prosecution agreement with U.S. department of justice.
Two Thousand And Twenty Five [Member]
Two Thousand And Twenty Five [Member]
Two thousand and twenty five.
Two Thousand And Twenty Four [Member]
Two Thousand And Twenty Four [Member]
Two thousand and twenty four.
Litigation Status [Axis]
Litigation Status [Domain]
Settled Litigation [Member]
Jurisdiction [Axis]
Statutory Accounting Practices, Jurisdiction [Domain]
Other Commitments [Axis]
Other Commitments [Domain]
Donation of Clotrimazole and Tobramycin [Member]
Donation of clotrimazole and tobramycin.
Fine for Violating the Antitrust Laws [Member]
Fine for violating the antitrust laws.
Income Tax [Table]
Income Tax [Table]
Income Tax [Table]
Income Tax Authority, Name [Axis]
Income Tax Authority, Name [Axis]
Income Tax Authority, Name [Domain]
Income Tax Authority, Name [Domain]
Israel Tax Authority [Member]
Israel Tax Authority [Member]
Income Tax [Line Items]
Income Tax [Line Items]
Income Tax [Line Items]
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent
Statutory tax rate in Israel
Expected Impairment OF Income Tax Benefit
Expected impairment of income tax benefit
Expected impairment of income tax benefit.
Income (Loss) from Continuing Operations before Income Taxes
Pre-tax income (loss)
Income (Loss) from Continuing Operations before Income Taxes.
Maximum Tax Payment Limit
Maximum tax payment limit
Maximum tax payment limit.
Effective Income Tax Rate Reconciliation, Tax Settlement, Other, Percent
Effective income tax rate reconciliation, tax settlement, other, percent
Number Of Years Spread To Pay Tax Payable
Number of years spread to pay tax payable
Number of years spread to pay tax payable.
Effective Income Tax Rate Reconciliation, Tax Settlement, Amount, Total
Effective Income Tax Rate Reconciliation, Tax Settlement, Amount, Total
Minimum Tax Rate
Minimum tax rate
Minimum tax rate.
Category of Item Purchased [Axis]
Category of Item Purchased [Axis]
Long-term Purchase Commitment, Category of Item Purchased [Domain]
Long-term Purchase Commitment, Category of Item Purchased [Domain]
Tax Credit Carryforward [Axis]
Tax Credit Carryforward [Axis]
Tax Credit Carryforward, Name [Domain]
Tax Credit Carryforward, Name [Domain]
Tax Period [Axis]
Tax Period [Axis]
Tax Period [Domain]
Tax Period [Domain]
Scenario [Axis]
Scenario, Unspecified [Domain]
Two Thousand Eight Through Tax Payable [Member]
Two Thousand Eight Through Tax Payable [Member]
Two thousand eight through tax payable .
Applicability [Axis]
Applicability.
Applicability [Domain]
Applicability.
Institution [Axis]
Institution.
Institution [Domain]
Institution.
Statutory Act [Axis]
Statutory Act [Domain]
Year Of Settlement [Axis]
Year of settlement
Year of settlement.
Year Of Settlement [Domain]
Year of settlement.
Restructuring And Impairment [Abstract]
Restructuring and impairment.
Restructuring And Impairment Costs [Table]
Restructuring And Impairment Costs [Table]
Restructuring And Impairment Costs [Table]
Restructuring And Impairment Costs [Line Items]
Restructuring and Impairment Costs [Line Items]
Restructuring and impairment costs.
Impairment, Long-Lived Asset, Held-for-Use
Impairment of long-lived tangible assets
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability
Contingent consideration
Business combination contingent consideration arrangements change in amount of contingent consideration liability
Restructuring Charges
Restructuring
Restructuring charges
Restructuring costs
Legal Settlements Loss Contingencies Impairments Other Expenses
Other
Legal settlements loss contingencies impairments other expenses.
Impairment And Restructuring
Total
Impairment and restructuring.
Impairment, Long-Lived Asset, Held-for-Use, Statement of Income or Comprehensive Income [Extensible Enumeration]
Impairment, Long-Lived Asset, Held-for-Use, Statement of Income or Comprehensive Income [Extensible Enumeration]
Restructuring and Related Activities [Abstract]
Schedule of Restructuring and Related Costs [Table]
Schedule of Restructuring and Related Costs [Table]
Restructuring Type [Axis]
Restructuring Type [Axis]
Type of Restructuring [Domain]
Type of Restructuring [Domain]
Employee Severance [Member]
Employee termination [Member]
Other Restructuring [Member]
Other [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Cost and Reserve [Line Items]
Exit And Disposal [Axis]
Exit And Disposal [Axis]
Exit And Disposal [Axis]
Exit And Disposal [Domain]
Exit And Disposal [Domain]
Exit And Disposal [Domain]
Employee Termination [Member]
Employee termination costs [Member]
Employee termination.
Other Exit And Disposal [Member]
Other Exit and Disposal [Member]
Other exit and disposal.
Restructuring Reserve
Beginning balance
Ending balance
Restructuring Accrual Provision
Provision
Restructuring Accrual Provision
Utilization And Other
Utilization and other
Utilization and other.
Tangible Asset Impairment Charges
Impairments of property, plant and equipment
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]
Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]
Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Net Income (Loss) Available to Common Stockholders, Diluted
Net income (loss) attributable to Teva's ordinary shareholders
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Diluted effect of stock options, RSUs and PSUs
Weighted average shares with anti-dilutive effect on earnings per share
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]
Antidilutive Securities [Axis]
Antidilutive Securities [Axis]
Antidilutive Securities, Name [Domain]
Antidilutive Securities, Name [Domain]
Convertible Preferred Stock [Member]
Convertible Preferred Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock
Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock
Equity [Table]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated Other Comprehensive Income (Loss) [Line Items]
AOCI Tax, Attributable to Parent
Beginning Balance
Ending Balance
OCI, before Reclassifications, before Tax, Attributable to Parent
Other comprehensive income (loss) before reclassifications
Reclassification from AOCI, Current Period, before Tax, Attributable to Parent
Amounts reclassified to the statements of income
Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent
Net other comprehensive income (loss) before tax
Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent
Corresponding income tax
Release of cumulative translation adjustments
Release of cumulative translation adjustments.
Accumulated Foreign Currency Adjustment Attributable to Parent [Member]
Foreign Currency Translation Adjustments [Member]
Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]
Derivative Financial Instruments [Member]
Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]
Benefit Plans [Member]
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest
Foreign currency translation attributable to non-controlling interests
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Other Operating Income (Expense)
Other loss (income)
Other Operating Income (Expense)
Cost of Revenue
Cost of Sales
Amounts Not Allocated To Segments [Abstract]
Amounts not allocated to segments.
Intangible Asset Impairments
Intangible asset impairments
Intangible Asset Impairments.
Other Unallocated Amounts
Other unallocated amounts.
Legal Settlements And Loss Contingencies Unallocated To Segments
Legal settlements and loss contingencies
The net proceeds or assets obtained in excess of (less than) the net carrying amount of assets recorded, or assets distributed and liabilities assumed less than (in excess of) litigation reserves extinguished, in settlement of a litigation matter. Represents (for other than an insurance entity in its normal claims settlement process), the amount of income (expense) recognized in the period to settle pending or threatened litigation and insurance claims and the aggregate amount provided for estimated restructuring charges, remediation costs, and asset impairment loss during an accounting period. Generally, these items are either unusual or infrequent, but not both (in which case they would be extraordinary items).
Amortization
Amortization
Amounts Allocated To Segments [Abstract]
Amounts allocated to segments.
Europe Segment [Member]
Europe [Member]
Europe segment.
United States Segment [Member]
United States [Member]
United States Segment [Member]
Other Segments [Member]
Other Segments [Member]
Corporate Segment [Member]
Corporate Segment [Member]
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Product Information [Table]
Schedule of Product Information [Table]
Product Information [Line Items]
Product Information [Line Items]
Generics Medicians Including OTC And Biosimilars [Member]
Generic products (including OTC and biosimilars) [Member]
Generics medicians including OTC and biosimilars.
COPAXONE [Member]
COPAXONE [Member]
COPAXONE.
BENDEKA and TREANDA [Member]
BENDEKA and TREANDA [Member]
BENDEKA and TREANDA.
Austedo [Member]
AUSTEDO [Member]
Austedo [Member]
Respiratory Product [Member]
Respiratory Product [Member]
Respiratory product.
Other Products [Member]
Other [Member]
Other Products [Member]
AJOVY [Member]
UZEDY [Member]
UZEDY [Member]
Revenue Type [Axis]
Revenue Type [Domain]
Schedule of Segment Reporting Information, by Segment [Table]
Schedule of Segment Reporting Information, by Segment [Table]
Concentration Risk Benchmark [Axis]
Concentration Risk Benchmark [Axis]
Concentration Risk Benchmark [Domain]
Concentration Risk Benchmark [Domain]
Concentration Risk Type [Axis]
Concentration Risk Type [Axis]
Concentration Risk Type [Domain]
Concentration Risk Type [Domain]
Segment Reporting Information [Line Items]
Segment Reporting Information [Line Items]
Number of Reportable Segments
Number of reportable segments
Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description
Segment Reporting, Expense Information Used by CODM, Description
Title and Position [Axis]
Title and Position [Domain]
Depreciation
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]
Fair Value Measurements, Recurring and Nonrecurring [Table]
Fair Value Measurements, Recurring and Nonrecurring [Table]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure
Cash and cash equivalents
Investments, Fair Value Disclosure
Investment in securities
Derivative Asset
Derivatives
Derivative Liability
Derivatives
Business Combination, Contingent Consideration, Liability
Contingent consideration
Fair Value, Net Asset (Liability)
Total
Asset Class [Axis]
Asset Class [Axis]
Asset Class [Domain]
Asset Class [Domain]
Money Market Funds [Member]
Money Markets [Member]
Demand Deposits [Member]
Cash, Deposits and Other [Member]
Equity Securities [Member]
Equity Securities [Member]
Other Restricted Cash [Member]
Other [Member]
Other restricted cash.
Fair Value Hierarchy and NAV [Axis]
Fair Value Hierarchy and NAV [Axis]
Fair Value Hierarchy and NAV [Domain]
Fair Value Hierarchy and NAV [Domain]
Fair Value, Inputs, Level 1 [Member]
Level 1 [Member]
Fair Value, Inputs, Level 2 [Member]
Level 2 [Member]
Fair Value, Inputs, Level 3 [Member]
Level 3 [Member]
Liability Class [Axis]
Liability Class [Axis]
Fair Value by Liability Class [Domain]
Fair Value by Liability Class [Domain]
Options And Forward Contracts Derivative Liabilities [Member]
Liabilities Derivatives Options and Forward Contracts [Member]
Options and forward contracts derivative liabilities.
Financial Instrument [Axis]
Financial Instrument [Axis]
Financial Instruments [Domain]
Financial Instruments [Domain]
Interest Rate Swap [Member]
Asset Derivatives - Options and Forward Contracts [Member]
Percentage Of Increase Decrease In Contingent Consideration Liabilities
Percentage of increase decrease in contingent consideration liabilities
Percentage of increase decrease in contingent consideration liabilities.
Weighted Average [Member]
Weighted Average [Member]
Fresh-Start Adjustments [Axis]
Fresh-Start Adjustments [Axis]
Type of Fresh-Start Adjustment [Domain]
Type of Fresh-Start Adjustment [Domain]
Nove Tide Acquisition [Member]
Nove tide acquisition.
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value
Fair value at the beginning of the period
Fair value at the end of the period
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Contingent Consideration Increase Decrease
Adjustments to provisions for contingent consideration
Fair value measurement with unobservable inputs reconciliation recurring basis liability contingent consideration increase decrease.
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements
Settlement of contingent consideration
Eagle Transaction [Member]
Eagle Transaction [Member]
Eagle transaction.
Allergan transaction [Member]
Debt Instrument, Fair Value Disclosure
Total
Seniornotesandconvertibleseniordebentures [Member]
Senior Notes and Convertible Senior Debentures Included Under Short-Term Debt [Member]
Senior notes and convertible senior debentures.
Senior Notes And Sustainability Linked Senior Notes [Member]
Senior Notes And Sustainability Linked Senior Notes [Member]
Senior notes and sustainability linked senior notes.